SIGA Technologies Inc.
SIGA to Present At The Homeland Security Investor Conference
Tuesday 14 October 2008
New York, New York, October 14, 2008 -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced that its CEO, Dr. Eric A. Rose, will be presenting at The Homeland Security Investor Conference on Wednesday, October 22, 2008 at The Ritz-Carlton Hotel in Washington, D.C. The conference, hosted by Imperial Capital, Capital Source and Civitas Group, will be attended by 30 prominent homeland security companies. Dr. Rose will give a 20-minute presentation regarding SIGA Technologies' market positioning, financial performance, and strategic direction, followed by a 10-minute question and answer session. The presentation slides will be available in the Investor Relations section of the Company’s website, Presentations. About SIGA Technologies, Inc. SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential biowarfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA’s Web site at Contact: Todd Fromer / Marybeth Csaby / David Burke KCSA Strategic Communications 212-896-1215 / 1236 / 1258 Tfromer@kcsa.com / mcsaby@kcsa.com / dburke@kcsa.com